The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The challenge of pediatric oncology: New business models to accelerate innovation.
 
Sonya Das
No Relationships to Disclose
 
Raphael F. Rousseau
Employment - Genentech/Roche; Gritstone Bio
Leadership - Gritstone Bio
Stock and Other Ownership Interests - Gritstone Bio; Roche
 
Peter C. Adamson
Stock and Other Ownership Interests - Gilead Sciences; Medtronic; Merck; Mylan
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Arog; AstraZeneca/MedImmune; Bayer; Celgene; Celgene; Eisai; Genentech/Roche; Janssen Research & Development; Nektar; United Therapeutics
 
Andrew W Lo
Leadership - BridgeBio Pharma; Roivant
Stock and Other Ownership Interests - BridgeBio Pharma; Ignyta; ImmuneXcite; KEW; LS Polaris Innovation Fund; MPM Capital; Roivant; Royalty Pharma
Consulting or Advisory Role - BridgeBio Pharma; Roivant
Other Relationship - Beth Israel Deaconess Medical Center; Milken Institute; MIT Whitehead Institute